Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001922560 | SCV002168008 | pathogenic | not provided | 2024-03-13 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Gln1913Profs*59) in the CAD gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CAD are known to be pathogenic (PMID: 28007989, 32117025, 32820246, 33497533). This variant is present in population databases (no rsID available, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with CAD-related conditions. ClinVar contains an entry for this variant (Variation ID: 1398412). For these reasons, this variant has been classified as Pathogenic. |
Fulgent Genetics, |
RCV005023404 | SCV005655944 | likely pathogenic | Developmental and epileptic encephalopathy, 50 | 2024-02-25 | criteria provided, single submitter | clinical testing |